A cryptopromoter is activated in the proliferating cell nuclear antigen gene of growth arrested cells
β Scribed by Christian Sell; Chung-Der Chang; Janice Koniecki; Hui-Min Chen; Renato Baserga
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 846 KB
- Volume
- 152
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
β¦ Synopsis
Massachusetts 02 125
We have examined the regulation of the proliferating cell nuclear antigen gene (PCNA) in a hamster fibroblast cell line (tk-tsl3) which is temperature sensitive for growth. These tk-tsl3 cells, at the restrictive temperature, are growth arrested in the G, phase of the cell cycle. The cells were stably transfected with a full length human PCNA gene, and the resulting cell lines (K525 cells) were analyzed. We find that, in growth arrested K525 cells, a cryptopromoter is activated in the transfected human PCNA gene. The cryptopromoter resides in intron 4 which is necessary for proper regulation of the PCNA gene. Removal of this intron leads to increased expression of PCNA in cells which have entered the Go state. An Alu sequence residing in intron 4 is implicated as the promoter element which is active during growth arrest, D 1992 WiIPy-iiss, \tic.
π SIMILAR VOLUMES
The GAS1 gene product induces growth arrest through a p53-dependent mechanism. To investigate whether GAS1 is a tumor suppressor gene, we transfected GAS1-negative human tumor cells with GAS1 plasmids and analyzed growth characteristics of stable transfectants. When a constitutively expressing GAS1
Pulmonary neuroendocrine cell products, especially bombesin-like peptides, are important modulators of fetal lung growth, morphogenesis and maturation. In the present study, we describe the ontogeny of protein gene product 9.5 (PGP 9.5) in 28 midtrimester human fetal lungs, in comparison to chromogr
## Abstract Vascular smooth muscle cell (VSMC) hyperplasia is responsible for the failure of 15β30% of vascular surgical procedures such as coronary artery bypass grafts and angioplasties. We and others have shown that heparin suppresses VSMC proliferation in vivo and in cell culture. We hypothesiz